Prolotherapy for the Treatment of Partial Rotator Cuff Tears
Status:
Not yet recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This is a Prospective Pilot Single Arm study on prolotherapy for the treatment of patients
with pain due to Partial Rotator Cuff (RC) Tears of the Shoulder.
The aim of this trial is to study the effects of injected glucose on injured or degenerative
RC tears of the shoulder. Glucose is not recognized by the FDA for this purpose but is used
in 2 main concentrations: 50% solution to treat hypoglycemia and 5% solution for fluid
replacement.
In the prolotherapy group, 20% dextrose will be injected into 4 locations of the affected
shoulder. In the active control group, patients will receive a single injection of
methylprednisolone into the subacromial bursa and 3 saline injections overlying the tendons.